Navigation Links
NINDS awards new Udall Centers for Parkinson's Disease Research
Date:9/29/2010

The National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health, has established two new sites as part of the Morris K. Udall Centers of Excellence in Parkinson's Disease Research. The NINDS grants will provide a five-year investment totaling more than $16 million for Emory University in Atlanta and the Feinstein Institute for Medical Research in Manhasset, N.Y.

NINDS Director Story Landis, Ph.D., announced the awards today at the World Parkinson Congress in Glasgow, Scotland. The congress is an international, interdisciplinary forum designed to showcase the latest developments in the world of Parkinson's disease, featuring a network of scientists, clinicians, patients, caregivers and allied health professionals from 66 countries.

"For more than a decade, the Udall Centers of Excellence have represented our commitment to bring together the talent and effort of the foremost investigators advancing research in Parkinson's disease," said Dr. Landis. "I look forward to these new centers partnering with us to accelerate basic, translational and clinical research to find a cure for this devastating illness."

Parkinson's disease is a degenerative disorder that attacks neurons in the substantia nigra, a part of the brain that controls movement. Symptoms include involuntary shaking, stiffened muscles and impaired balance. Although certain drugs, such as levodopa, can reduce Parkinson's disease symptoms, there is no proven method to slow its progressive course.

With the new centers announced today, NINDS is supporting 11 Udall Centers of Excellence across the United States. The grants provide funding for a wide range of independent and collaborative projects. These include genetic and genomic studies, research to pinpoint the disease's underlying mechanisms, work to improve animal models, the development and testing of potential therapeutics, and clinical research with Parkinson's disease patients. The NINDS launched the network in 1997. The Udall Centers are named in honor of U.S. Rep. Morris K. Udall (D-Ariz.), who died in 1998 after a long battle with Parkinson's disease.

Thomas Wichmann, M.D., professor of neurology at Emory University, will direct the new Udall Center. One of its objectives is to enhance collaboration between basic scientists with the university's clinical movement disorders group, which works with Parkinson's disease patients in the Atlanta region. The program will bring together experts in electrophysiology, pharmacology and related disciplines investigating brain circuits disrupted by Parkinson's disease and the effects of treating them with pharmacological and surgical therapy. The center also will include a research component at Vanderbilt University in Nashville. "Our goal is to increase understanding of how existing therapies work, and develop and explore the mechanisms of action of new antiparkinsonian treatments," said Dr. Wichmann.

The director of the new Udall Center at the Feinstein Institute for Medical Research is David Eidelberg, M.D., a pioneer in the use of functional brain imaging and network analysis for the study of neurodegenerative diseases and Parkinson's disease. The new center will focus on working with patients who suffer serious clinical side effects from levodopa and examining individual differences in the cognitive response to treatment.

"Understanding these phenomena should not only help improve the lives of patients, but also provide unique insight into the pathophysiology of Parkinson's disease and its treatment," said Dr. Eidelberg. He added that the center will work toward validating a novel method for imaging brain circuits to aid early diagnosis, which could help streamline trials of new therapies for Parkinson's disease as well as for atypical parkinsonian syndromes.

NINDS program director Beth-Anne Sieber, Ph.D., said, "By virtue of cutting-edge, collaborative research approaches, the Udall Centers of Excellence are uniquely poised to advance scientific discovery toward improved understanding of this disease, as well as treatment of people with Parkinson's disease. We look forward to working with the Emory, Feinstein and other Udall Centers on these important goals."


'/>"/>

Contact: Gregory Roa
greg.roa@nih.gov
301-496-5751
NIH/National Institute of Neurological Disorders and Stroke
Source:Eurekalert

Related biology news :

1. Penn Vet announces $100,000 winners of 2010 World Leadership Award and Student Inspiration Awards
2. MARC Travel Awards announced for the 2010 SACNAS Annual Meeting
3. MARC Travel Awards announced for the 2010 Biomedical Engineering Society Annual Meeting
4. MARC Travel Awards announced for the 2010 Society for Leukocyte Biology Meeting
5. MARC Travel Awards announced: The 2010 Società Italiana di Patologia XXX National Congress
6. Top cancer specialists receive ESMO awards
7. ORNL wins 2 awards for sustainability program
8. Novartis awards 2010 Prizes for Immunology in recognition of outstanding contributions to immunology in medical research
9. Iowa State awards grants to develop health, energy and research technologies
10. NSF awards $10M to develop computing techniques for measuring and analyzing child behavior
11. NOAA awards grant to investigate impacts of land use and climate change on hypoxia in Green Bay
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)...  IBM (NYSE: IBM ) is introducing several innovative ... to developing collaboration between startups and global businesses, taking place ... the event, nine startups will showcase the solutions they have ... France is one ... a 30 percent increase in the number of startups created ...
(Date:4/24/2017)... WASHINGTON , April 24, 2017 ... counsel and partner with  Identity Strategy Partners, LLP ... "With or without President Trump,s March 6, ... Foreign Terrorist Entry , refugee vetting can be instilled ... refugee resettlement. (Right now, all refugee applications are ...
(Date:4/13/2017)... 2017 According to a new market research report ... Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region ... expected to grow from USD 14.30 Billion in 2017 to USD 31.75 ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... CA (PRWEB) , ... October 11, 2017 , ... ... upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding the ... system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
(Date:10/10/2017)... ... 10, 2017 , ... USDM Life Sciences , the ... sciences and healthcare industries, announces a presentation by Subbu Viswanathan and Jennifer Jaye ... GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach to achieving ...
Breaking Biology Technology: